Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05577182
Title Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ESP | BEL

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute Los Angeles California 90025 United States Details
University of Texas Md Anderson Cancer Center Houston Texas 77030 United States Details
Cliniques Universitaires Ucl Saint-Luc Bruxelles 01200 Belgium Details
Universitair Ziekenhuis Antwerpen (Uza) Edegem 02650 Belgium Details
Universitair Ziekenhuis Gent Gent 09000 Belgium Details
Universitair Ziekenhuis Brussel Jette 01090 Belgium Details
Chu Ucl Namur University Hospital Mont-Godinne Yvoir 05530 Belgium Details
Centro Ricerche Cliniche Di Verona (Crc) Verona 37134 Italy Details
Hospital Quironsalud Barcelona Barcelona 08023 Spain Details
Ico Institut Catala D Oncologia L'hospitalet de Llobregat 08906 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Centro Integral Oncologico Clara Campal Madrid 28050 Spain Details
Hospital Universitario Quironsalud Madrid Pozuelo de Alarcón 28223 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field